Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MitraClip REPAIR MR Study

NCT: NCT04198870 · ACTIVE_NOT_RECRUITING

NCT IDNCT04198870
StatusACTIVE_NOT_RECRUITING
Start Date2020-07-21
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑